Delivery Order SPE2DB22D2006-SPE2DB25FV8VD

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,490.04, is for the procurement of SPRAVATO 84 MG DOSE PACK UDS, a medical product. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,255.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of SPRAVATO 56 MG DOSE PACK UDS, a pharmaceutical product, with a completion date of December 12, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $8,627.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a medical product, with a ceiling value of $22,963.32 and a completion date of November 15, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
The Defense Logistics Agency awarded a $1,417.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561835820 SPRAVATO 56 MG DOSE PACK UDS. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will deliver the pharmaceutical products to the same location by August 17, 2023. This delivery order was issued against an existing DLA contract vehicle to supply SPRAVATO, an esketamine nasal spray used to treat...
This federal contract award, with an ID of SPE2DX15D6028|SPE2DX25FWEJS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,827.22 firm fixed-price delivery order is for the supply of 4,566,192,266 units of the drug Esketamine, with an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DX15D1022|SPE2DX19F5TPL, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $92,971.20 fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to supply a broad range of pharmaceutical products and medical supplies. The contract has no set-aside designation, indicating open competition....
The federal contract award, with ID SPE2DX22D0020|SPE2D825F06JK, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $935,961.21 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of November 18, 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This federal contract award, with ID SPE2DX22D0019 and SPE2D825FAY18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,282.88 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical that runs through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, with ID SPE2DX16D4016|SPE2DX25FFEPT, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm fixed-price delivery order contract is with the Defense Logistics Agency (DLA) Troop Support Medical, and has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8VD
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2006|SPE2DB25FV8VD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,028.97 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK medical products.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/3/25, 9:55 AM